Dolutegravir/Abacavir/Lamivudine in Acute HIV-1 Results in Rapid Suppression and Restoration of CD4 T-cell Subsets Without Accelerated Decay of Latent HIV-1
Open Access
- 24 April 2025
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (5) , ofaf247
Abstract
Background: We evaluated rapid start of integrase-based antiretroviral therapy (ART) during acute HIV-1. Methods: Adult participants initiated co-formulated dolutegravir/abacavir/lamivudine within 30 days of acute HIV-1 diagnosis. HLA-B*57-positive participants were excluded by rapid, flow cytometry screening. We evaluated HIV-1 RNA levels, CD4+ T-cell subsets, and change in replication competent HIV-1. Results: Forty adults screened with 3 excluded due to positive HLA-B*57:01 or hepatitis B surface antigen results. All 37 participants starting study treatment suppressed to <200 copies/mL by week 24 (median of 4 weeks, interquartile range 3.4–5.1); 86% and 95% were <50 copies/mL at weeks 48 and 96, respectively. We observed a median 2.4-fold decline in frequency of resting CD4+ T-cell infection in a subset of participants providing 96 week samples. ART in acute HIV-1 resulted in CD4+ T-cell memory subpopulations similar to people without HIV-1 and preserved CD4+ and CD8+ T-cell frequencies compared to people starting ART in chronic HIV. Thirty-four participants required rapid HLA-B*57 testing at screening; 97% resulted ≤24 hours, and 71% started ART ≤24 hours. Conclusions: Integrase-based ART during acute HIV-1 resulted in brisk viral suppression, preservation of CD4+ T-cell subsets, and decline in resting CD4+ T-cell infection.Keywords
This publication has 45 references indexed in Scilit:
- Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infectionInternational Journal of STD & AIDS, 2011
- Integrase and Fusion Inhibitors Transmitted Drug Resistance in Naive Patients With Recent Diagnosis of HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Sustained Antiretroviral Effect of Raltegravir After 96 Weeks of Combination Therapy in Treatment-Naive Patients With HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Emergence of Polyfunctional CD8+T Cells after Prolonged Suppression of Human Immunodeficiency Virus Replication by Antiretroviral TherapyJournal of Virology, 2008
- Effect of Treatment, during Primary Infection, on Establishment and Clearance of Cellular Reservoirs of HIV-1The Journal of Infectious Diseases, 2005
- Initiation of Antiretroviral Therapy During Recent HIV-1 Infection Results in Lower Residual Viral ReservoirsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Interleukin 7 Regulates the Survival and Generation of Memory CD4 CellsJournal of Experimental Medicine, 2003
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001
- Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 InfectionJournal of Experimental Medicine, 2001
- HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapyJournal of Clinical Investigation, 1999